Company Monitoring Page for Sandoz

latest headlines for company on cafepharma

A perfect storm: Europe's generic industry weighs cuts to output amid energy crisis, pricing pressures and more
Fierce Pharma
Wed, 09/28/22 - 11:38 am
Tags:
generics, Europe, Teva Pharmaceutical, Sandoz
Unsealed documents detail Biogen's fight against Sandoz Tysabri biosimilar
Endpoints
Tue, 09/20/22 - 08:36 pm
Tags:
Biogen, Novartis, Sandoz, biosimilars, Tysabri, MS, multiple sclerosis
Sandoz reports data from Phase I/III trial of denosumab for osteoporosis
Clinical Trials Arena
Tue, 09/20/22 - 10:07 am
Tags:
Novartis, Sandoz, clinical trials, biosimilarts, denosumab, osteoporosis
Novartis cuts manufacturing jobs, closes North Carolina plant ahead of Sandoz spinoff
Fierce Pharma
Fri, 08/26/22 - 10:45 am
Tags:
Novartis, drug manufacturing, Sandoz, generics
It's a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs of recovery
Fierce Pharma
Thu, 08/25/22 - 11:30 am
Tags:
spinoffs, Novartis, Sandoz, generics
FDA reviewing higher dose Hyrimoz biosimilar
Biopharma Reporter
Fri, 07/22/22 - 11:14 am
Tags:
FDA, Sandoz, biosimilars, Hyrimoz, Humira, AbbVie
Novartis, staring down tough market for M&A, leans toward $25B Sandoz spinoff: Bloomberg
Fierce Pharma
Fri, 07/1/22 - 09:49 am
Tags:
Novartis, spinoffs, generics, M&A, Sandoz, private equity
More drug, fewer jabs: Novartis' Sandoz eyes EMA nod for high-concentration Humira copy
Fierce Pharma
Mon, 06/20/22 - 10:37 am
Tags:
Novartis, Sandoz, AbbVie, Humira, Europe, biosimilars, autoimmune disease, EMA, Hyrimoz
Novartis’ Sandoz Launches Biosimilars Awareness Campaign to Improve Biosimilars Adoption Worldwide
Xtalks
Wed, 06/8/22 - 11:04 pm
Tags:
Novartis, Sandoz, biosimilars, generics
Novartis' Sandoz founds new initiative to expand biosimilar use more globally
Endpoints
Tue, 05/31/22 - 11:51 pm
Tags:
Novartis, Sandoz, biosimilars
Novartis' Sandoz strikes at Roche with first US generic of blockbuster Esbriet
Fierce Pharma
Fri, 05/13/22 - 10:46 am
Tags:
Novartis, Sandoz, generics, Roche, Esbriet, idiopathic pulmonary fibrosis
Novartis' Sandoz, following Pfizer's lead, launches 2nd carcinogen-related drug recall this week
Fierce Pharma
Wed, 03/23/22 - 10:58 pm
Tags:
Novartis, Sandoz, product recalls, generics
Novo Nordisk and Novartis put Victoza patent suit to bed, teeing up Sandoz copycat by 2024
Fierce Pharma
Wed, 03/23/22 - 10:38 am
Tags:
Novo Nordisk, Novartis, Sandoz, Victoza, generics, patents, diabetes
Sandoz bulks up ahead of possible sale with Coalesce buy
Pharmaforum
Mon, 03/14/22 - 10:21 am
Tags:
Novartis, Sandoz, generics, M&A, Coalesce Product Development
Novartis sells pair of manufacturing plants as Sandoz strategic review rolls on
Fierce Pharma
Thu, 03/3/22 - 10:19 am
Tags:
Novartis, drug manufacturing, Sandoz
No news anytime soon on Sandoz sale, says Novartis
Pharmaforum
Thu, 02/3/22 - 10:35 am
Tags:
Novartis, Vas Narasimhan, Sandoz, generics, M&A
Novartis (NVS) Q4 Earnings & Sales Miss, Sandoz Review Ongoing
NASDAQ
Wed, 02/2/22 - 11:44 pm
Tags:
Novartis, earnings, Sandoz
Novartis' Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone
Fierce Pharma
Tue, 02/1/22 - 11:26 pm
Tags:
Novartis, Sandoz, M&A, Blackstone, Carlyle
Teva and Novartis’ Sandoz launch Narcan generics on same day, brand marketer Emergent remains in play
Endpoints
Wed, 01/5/22 - 10:47 pm
Tags:
Teva Pharmaceutical, Novartis, Sandoz, generics, Narcan, Emergent BioSolutions
Spinoff updates: Merck’s Organon and Novartis’ Sandoz
Generics and Biosimilar Initiative
Mon, 11/29/21 - 11:08 pm
Tags:
spinoffs, Merck, Organon, earnings, Novartis, Sandoz, biosimilars

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.